EUVIMEDEUVIMED entdecken
Crossref

Non‐acidic Biarylcarbaldehydes as Potent COX‐2 Inhibitors: Design, Microwave Synthesis, and Multidisciplinary Validation With Improved Gastrointestinal Safety

Katia Mohand Saidi, Bassam A Najri, Mohamed Zakaria Stiti, Abdelmadjid Guendouzi, Kamel Harrouche, Arif Kivrak, Smail Khelili iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.202502322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Katia Mohand Saidi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Exact Sciences and Informatics, University of Mohamed Seddik Ben Yahia - Jijel, Jijel, Algeria. Hauptthemen laut MEDLINE: Microwaves, Drug Design, Cyclooxygenase 2 Inhibitors, Cyclooxygenase 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Algerian Ministry of Higher Education and Scientific Research, Directorate General for Scientific Research and Technological Development, University of Osmangazi Eskisehir, Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study delineates the rational design, microwave‐assisted synthesis, and comprehensive pharmacological evaluation of a novel series of nonacidic biarylcarbaldehydes ( 1a–l ) as selective COX‐2 inhibitors. The methodology involved substituting the conventional acidic pharmacophore in NSAIDs with a neutral aldehyde to enhance gastrointestinal safety. The derivatives were synthesized with high yields (90%–99%) through an optimized Suzuki–Miyaura cross‐coupling procedure. In silico ADMET analysis demonstrated excellent drug‐like characteristics and oral bioavailability throughout the series. Docking studies revealed strong binding affinities to COX‐2, particularly for compound 1 g (MolDock score: −136.79 kcal/mol), with critical interactions at Tyr385 and Trp387 residues. To assess metabolic stability, the acidic metabolites ( 2a–l ) were modeled, maintaining or improving enzymatic affinity. Molecular dynamics simulations (100 ns) confirmed the structural stability of these complexes. In vivo evaluation utilizing the carrageenan‐induced rat paw edema model supported the computational findings, with lead compound 1 g achieving complete edema reduction at 4 h, surpassing diclofenac. These results suggest that biarylcarbaldehyde frameworks serve as promising nonacidic alternatives for anti‐inflammatory therapy with an improved safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrowavesDrug DesignCyclooxygenase 2 InhibitorsCyclooxygenase 2AldehydesAnti-Inflammatory Agents, Non-SteroidalGastrointestinal TractAnimalsRatsEdemaMolecular Docking SimulationStructure-Activity RelationshipCarrageenanMolecular StructureMolecular Dynamics SimulationHumansMale

Stichwörter der Autor:innen

Suzuki–Miyaura couplinggastrointestinal Safetyin silico studyin vivo anti‐inflammatory activitymicrowave‐assisted synthesis

Substanzen

Cyclooxygenase 2 InhibitorsCyclooxygenase 2AldehydesAnti-Inflammatory Agents, Non-SteroidalCarrageenan

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Exact Sciences and Informatics, University of Mohamed Seddik Ben Yahia - Jijel, Jijel, Algeria.
  • Laboratory of Phytochemistry and Pharmacology, Pharmaceutical Chemistry team, University of Mohamed Seddik Ben Yahia - Jijel, Jijel, Algeria.
  • Department of Chemistry, Faculty of Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Higher Normal School (ENS), Constantine, Algeria.
  • Pharmaceutical Sciences Research Center (CRSP), Constantine, Algeria.

ORCID-Profile: Smail Khelili

Förderung

  • Algerian Ministry of Higher Education and Scientific Research
  • Directorate General for Scientific Research and Technological Development
  • University of Osmangazi Eskisehir, Turkey
  • YTB Turkish scholarship
  • Direction Générale de la Recherche Scientifique et du Développement Technologique

Zitieren

APA

Mohand Saidi, K., A Najri, B., Stiti, M. Z., Guendouzi, A., Harrouche, K., Kivrak, A., & Khelili, S. (2026). Non‐acidic Biarylcarbaldehydes as Potent COX‐2 Inhibitors: Design, Microwave Synthesis, and Multidisciplinary Validation With Improved Gastrointestinal Safety. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502322

Vancouver

Mohand Saidi K, A Najri B, Stiti MZ, Guendouzi A, Harrouche K, Kivrak A, et al. Non‐acidic Biarylcarbaldehydes as Potent COX‐2 Inhibitors: Design, Microwave Synthesis, and Multidisciplinary Validation With Improved Gastrointestinal Safety. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502322

BibTeX
@article{MohandSaidi2026,
  author = {Mohand Saidi, Katia and A Najri, Bassam and Stiti, Mohamed Zakaria and Guendouzi, Abdelmadjid and Harrouche, Kamel and Kivrak, Arif and Khelili, Smail},
  title = {Non‐acidic Biarylcarbaldehydes as Potent COX‐2 Inhibitors: Design, Microwave Synthesis, and Multidisciplinary Validation With Improved Gastrointestinal Safety},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.202502322}
}
Kostenlos starten →